Head-To-Head Contrast: West Pharmaceutical Services (WST) & Asante Solutions (PUMP)
Asante Solutions (NASDAQ: PUMP) and West Pharmaceutical Services (NYSE:WST) are both medical equipment, supplies & distribution – nec companies, but which is the superior business? We will compare the two companies based on the strength of their profitability, dividends, risk, analyst recommendations, institutional ownership, valuation and earnings.
This is a breakdown of current recommendations and price targets for Asante Solutions and West Pharmaceutical Services, as reported by MarketBeat.
|Sell Ratings||Hold Ratings||Buy Ratings||Strong Buy Ratings||Rating Score|
|West Pharmaceutical Services||0||2||2||0||2.50|
Asante Solutions currently has a consensus price target of $20.67, suggesting a potential upside of Infinity. West Pharmaceutical Services has a consensus price target of $106.00, suggesting a potential upside of 6.49%. Given Asante Solutions’ stronger consensus rating and higher probable upside, analysts clearly believe Asante Solutions is more favorable than West Pharmaceutical Services.
Earnings & Valuation
This table compares Asante Solutions and West Pharmaceutical Services’ revenue, earnings per share and valuation.
|Gross Revenue||Price/Sales Ratio||Net Income||Earnings Per Share||Price/Earnings Ratio|
|West Pharmaceutical Services||$1.51 billion||4.90||$143.60 million||$2.51||39.66|
West Pharmaceutical Services has higher revenue and earnings than Asante Solutions.
This table compares Asante Solutions and West Pharmaceutical Services’ net margins, return on equity and return on assets.
|Net Margins||Return on Equity||Return on Assets|
|West Pharmaceutical Services||12.12%||14.47%||9.71%|
Institutional and Insider Ownership
93.3% of West Pharmaceutical Services shares are held by institutional investors. 1.9% of West Pharmaceutical Services shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company is poised for long-term growth.
West Pharmaceutical Services pays an annual dividend of $0.56 per share and has a dividend yield of 0.6%. Asante Solutions does not pay a dividend. West Pharmaceutical Services pays out 22.3% of its earnings in the form of a dividend. Asante Solutions has raised its dividend for 24 consecutive years.
West Pharmaceutical Services beats Asante Solutions on 7 of the 13 factors compared between the two stocks.
About Asante Solutions
Asante Solutions, Inc. is a medical device company. The Company is a manufacturer of Asante Snap Insulin Pump System (Snap system), which is a pump featuring a modular design with pre-filled insulin cartridges and disposable pump bodies, utilized in combination with a controller. The Snap system comprises four components: the Snap system controller, a disposable pump body, disposable pre-filled insulin cartridges and disposable infusion sets. The Snap system also incorporates a technology that allows for auto-priming, whereby, without user intervention, the infusion tubing is automatically filled with insulin every time a new cartridge is inserted. The disposable pump body, which contains a fresh battery, is designed to be used for a week. The Company markets the Snap system through distributors of medical equipment and supplies to individuals with diabetes.
About West Pharmaceutical Services
West Pharmaceutical Services, Inc. is a manufacturer of packaging components and delivery systems for injectable drugs and healthcare products. The Company’s products include vial containment solutions, prefillable systems, self-injection platforms, cartridge systems and components, reconstitution and transfer systems, intradermal delivery solutions, specialty components, and contract manufacturing and analytical services. The Company’s segments include Proprietary Products and Contract-Manufactured Products. The Proprietary Products segment develops commercial and operational strategies across its global network, with specific emphasis on product offerings to biologic, generic and pharmaceutical drug customers. The Contract-Manufactured Products segment serves as an integrated business focused on the design, manufacture and automated assembly of various devices, primarily for pharmaceutical, diagnostic and medical device customers.
Receive News & Ratings for Asante Solutions Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Asante Solutions and related companies with MarketBeat.com's FREE daily email newsletter.